Product Program year 2019 Source: CMS Open Payments

MPS I-Disease

Drug

Open in the dashboard

General payments

$1,658

95 payments

Research payments

$48,220

48 payments

Through program year 2019, $1,658 in general payments and $48,220 in research payments were reported against MPS I-Disease.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $1,658 95
2019 Research $48,220 48

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $1,658 95 payments
Top recipients General payments · program year 2019
  1. Dmitriy Niyazov Clinical Genetics (M.D.) · Durham, NC $103 6% · 5 payments
  2. Paul Orchard Pediatric Hematology-Oncology · Minneapolis, MN $66 4% · 1 payment
  3. David Liebergall Ophthalmology · Suffern, NY $58 3% · 3 payments
  4. Raymund David Neurology with Special Qualifications in Child Neurology · Madera, CA $58 3% · 3 payments
  5. Joseph Paskowski Ophthalmology · Suffern, NY $40 2% · 2 payments

The top 5 of 76 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Clinical Genetics (M.D.) Medical Genetics $328 20% · 13 practitioners
  2. Ophthalmology $272 16% · 13 practitioners
  3. Pediatrics $196 12% · 9 practitioners
  4. Family Medicine $189 11% · 9 practitioners
  5. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $156 9% · 4 practitioners

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. New York $338 20% · 16 recipients
  2. California $222 13% · 7 recipients
  3. Kansas $207 12% · 10 recipients
  4. Louisiana $142 9% · 2 recipients
  5. Tennessee $122 7% · 6 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

95 general · 48 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record